Subsequent close of Series B financing, total raised US$ 39 million
31 January 2022
Subsequent Close of Series B Financing, Total Raised $39 million
Boulder CA, USA: 31 January 2022 – DMC Biotechnologies, Inc. announces that strategic investors Continental Grain Company, through their venture arm Conti Ventures, and Toyobo have joined the Series B fundraising round, bringing the total raised to $39 million.
DMC previously announced the first close of its Series B fundraising on 2 December 2021 with investment from Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy Ventures, SCG, Boulder Ventures, Solvay Ventures and Michelin.
More info on DMC‘s website.